These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5539640)

  • 21. The modifications of the final stages of the complement reaction by alkali metal cations.
    Dalmasso AP; Lelchuk R; Giavedoni EB; De Isola ED
    J Immunol; 1975 Jul; 115(1):63-8. PubMed ID: 239058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new activity of complement component C3: cell-bound C3b potentiates lysis of erythrocytes by C5b,6 and terminal components.
    Hammer CH; Abramovitz AS; Mayer MM
    J Immunol; 1976 Sep; 117(3):830-4. PubMed ID: 956655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Independent and consecutive action of the complement components C5, C6 and C7 in immune hemolysis. I. Preparation of EAC1-5 with purified guinea pig C3 and C5.
    Bitter-Suermann D; Hadding U; Melchert F; Wellensiek HJ
    Immunochemistry; 1970 Dec; 7(12):955-65. PubMed ID: 5503627
    [No Abstract]   [Full Text] [Related]  

  • 24. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The activation of C5 in the fluid phase and in the absence of C3 through the classical pathway of the complement system.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Jul; 58(3):459-65. PubMed ID: 3733147
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activation of the fifth and sixth components of the human complement system: C6-dependent cleavage of C5 in acid and the formation of a bimolecular lytic complex, C5b,6a.
    Hammer CH; Hänsch G; Gresham HD; Shin ML
    J Immunol; 1983 Aug; 131(2):892-8. PubMed ID: 6863934
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deviated lysis: Transfer of complement lytic activity to unsensitized cells II. Generation of the activity by inulin and by antigen antibody complexes.
    Rother U; Hänsch G; Rother K
    Z Immunitatsforsch Immunobiol; 1976 Aug; 151(1):442-54. PubMed ID: 785847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.
    Kolb WP; Müller-Eberhard HJ
    J Exp Med; 1973 Aug; 138(2):438-51. PubMed ID: 4719679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of antibody and complement in the immune clearance and destruction of erythrocytes. II. Molecular nature of IgG and IgM complement-fixing sites and effects of their interaction with serum.
    Schreiber AD; Frank MM
    J Clin Invest; 1972 Mar; 51(3):583-9. PubMed ID: 4622104
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the terminal stages of immune hemolysis. III. Distinction between the insertion of C9 and the formation of a transmembrane channel.
    Boyle MD; Langone JJ; Borsos T
    J Immunol; 1978 May; 120(5):1721-25. PubMed ID: 659873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the complement attack mechanism in the fluid phase and its control by C567-INH: lysis of normal erythrocytes initiated by zymosan, endotoxin, and immune complexes.
    Lint TF; Behrends CL; Baker PJ; Gewurz H
    J Immunol; 1976 Nov; 117(5 Pt 1):1440-6. PubMed ID: 1002985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The structural events associated with the attachment of complement components to cell membranes in reactive lysis.
    Dourmashkin RR
    Immunology; 1978 Aug; 35(2):205-12. PubMed ID: 750370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evidence for the influence of the initial complement components on the assembly and activity of the membrane attack complex.
    Boyle MD; Ohanian SH
    J Immunol; 1980 Jun; 124(6):2824-7. PubMed ID: 7373051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Determination of the number of lytic sites in biconcave and spheroid erythrocyte ghosts after complement lysis.
    Bauer J; Podack ER; Valet G
    J Immunol; 1979 May; 122(5):2032-6. PubMed ID: 448115
    [No Abstract]   [Full Text] [Related]  

  • 35. The indiction by complement of a change in KSCN-dissociable red cell membrane lipids.
    Giavedoni EB; Dalmasso AP
    J Immunol; 1976 Apr; 116(4):1163-9. PubMed ID: 1254965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Homologous species restriction in lysis of erythrocytes by terminal complement proteins.
    Hänsch GM; Hammer CH; Vanguri P; Shin ML
    Proc Natl Acad Sci U S A; 1981 Aug; 78(8):5118-21. PubMed ID: 6946459
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monoclonal antibodies as probes to investigate the molecular changes of C5 associated with the different stability of the molecule on sheep erythrocytes and Escherichia coli 0111:B4.
    Rottini G; Roncelli L; Narchi G; Patriarca P; Protani G; Perissutti S; Tedesco F
    J Immunol; 1991 Jan; 146(2):643-7. PubMed ID: 1987280
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C3-independent immune haemolysis: mechanism of membrane attack complex formation.
    Kitamura H; Tsuboi M; Nagaki K
    Immunology; 1986 Sep; 59(1):147-51. PubMed ID: 3759127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Membrane attack complex of complement: a structural analysis of its assembly.
    Podack ER; Esser AF; Biesecker G; Müller-Eberhard HJ
    J Exp Med; 1980 Feb; 151(2):301-13. PubMed ID: 7356725
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.